Seroconversion to islet autoantibodies may predict type 1 diabetes

06/18/2013 | Clinical Endocrinology News

The odds of entering a preclinical stage of type 1 diabetes at age 15 were 79% in children who carried islet antibodies against insulin, glutamic acid decarboxylase and insulinoma antigen 2, compared with 0.4% in children who had no islet autoantibodies, German researchers found. The rate of progression to diabetes was faster among those who seroconverted before age 3, according to the study in the Journal of the American Medical Association.

View Full Article in:

Clinical Endocrinology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ